|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives The Advisory Board Co. a score of 47. Our analysis is based on comparing The Advisory Board Co. with the following peers – Gartner, Inc., National Research Corporation Class B, INC Research Holdings, Inc. Class A and Quest Diagnostics Incorporated (IT-US, NRCIB-US, INCR-US and DGX-US). Investment Outlook ... Read more (Read more...)
Advisory Board provides insights on consumer understanding, service redesign, and targeted marketing to break through growth stagnation WASHINGTON , Nov. 16, 2017 /PRNewswire/ -- Health systems can no ...
WASHINGTON and BOSTON, Nov. 15, 2017 /PRNewswire/ -- The Advisory Board Company (ABCO) and Optum announced that, at a special meeting of Advisory Board stockholders held today, stockholders holding a majority of the outstanding shares of the company's common stock voted to approve the adoption of the previously disclosed merger agreement with Optum. Pursuant to the agreement, Optum will acquire Advisory Board through a merger and, as previously disclosed, Advisory Board will sell its education business to affiliates of Vista Equity Partners prior to the closing of the merger, which is expected to be completed Friday, November 17, 2017.
WASHINGTON, Nov. 14, 2017 /PRNewswire/ -- Hospitals and health systems have been improving important portions of their revenue cycle performance over the past two years but face rising risks from increased denial writeoffs, bad debt, and inefficiencies revealed by their persistently high costs to collect, according to Advisory Board's latest Revenue Cycle Survey. Notably, a median 350-bed hospital would have lost $3.5 million to increased denial writeoffs from health care payers over the past four years, the benchmarks show. "Across the revenue cycle as a whole, the benchmarks are encouraging and yet show the risks of complacency," said Jim Lazarus, National Partner, Technology at Advisory Board.
Advisory Board's national partners share insights on how leading providers are reducing care variation to cut costs and improve patient outcomes WASHINGTON , Nov. 13, 2017 /PRNewswire/ -- As more costs ...
On a per-share basis, the Washington-based company said it had profit of 2 cents. Earnings, adjusted for one-time gains and costs, came to 27 cents per share. The results did not meet Wall Street expectations. ...
WASHINGTON , Nov. 8, 2017 /PRNewswire/ -- The Advisory Board Company (NASDAQ: ABCO) today announced financial results for the third quarter and nine-month period ended September 30, 2017 . Third Quarter ...
A Relative Strength Rating upgrade for Advisory Board Company shows improving technical performance. Will it continue?
Advisory Board Company shows improving price performance, earning an upgrade to its IBD Relative Strength Rating